Anticancer Drug Discovery Targeting DNA Hypermethylation

E-ISSN： 1875-533x|15|14|1350-1375

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.15, Iss.14, 2008-06, pp. : 1350-1375

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting Protein Tyrosine Phosphatases for Anticancer Drug Discovery

Current Pharmaceutical Design, Vol. 16, Iss. 16, 2010-06 ,pp. : 1843-1862

Bentham Science Publishers

Access to resources Recommend Favorite

Epigenetic Therapy: Histone Acetylation, DNA Methylation and Anti-Cancer Drug Discovery

Current Cancer Drug Targets, Vol. 9, Iss. 8, 2009-12 ,pp. : 963-981

Bentham Science Publishers

Access to resources Recommend Favorite

Current Targets for Anticancer Drug Discovery

Current Drug Targets, Vol. 4, Iss. 2, 2003-02 ,pp. : 159-179

Bentham Science Publishers

Access to resources Recommend Favorite

Titanocene Y and Vanadocene Y: Platinum Resistance-Breaking Cytotoxic and DNA-Targeting Anticancer Drug Candidates

Letters in Drug Design & Discovery, Vol. 8, Iss. 10, 2011-12 ,pp. : 904-910

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting enzyme inhibitors in drug discovery

By Copeland Robert A Harpel Mark R Tummino Peter J

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 7, 2007-07 ,pp. : 967-978

Informa Healthcare

Access to resources Recommend Favorite